BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 37600785)

  • 1. Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy.
    Zheng Z; Su J; Bao X; Wang H; Bian C; Zhao Q; Jiang X
    Front Immunol; 2023; 14():1247268. PubMed ID: 37600785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications.
    Liu R; Peng L; Zhou L; Huang Z; Zhou C; Huang C
    Antioxidants (Basel); 2022 Apr; 11(5):. PubMed ID: 35624717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
    Gu X; Liu Y; Dai X; Yang YG; Zhang X
    Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in the tumor microenvironment in gastric cancer and its potential role in immunotherapy.
    Yu Y; Wu Y; Zhang Y; Lu M; Su X
    FEBS Open Bio; 2023 Jul; 13(7):1238-1252. PubMed ID: 37171226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fe-MnO
    Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
    Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanointegrative In Situ Reprogramming of Tumor-Intrinsic Lipid Droplet Biogenesis for Low-Dose Radiation-Activated Ferroptosis Immunotherapy.
    Zhang Q; Wang X; Zhao Y; Cheng Z; Fang D; Liu Y; Tian G; Li M; Luo Z
    ACS Nano; 2023 Dec; 17(24):25419-25438. PubMed ID: 38055636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.
    Jin Z; Sun X; Wang Y; Zhou C; Yang H; Zhou S
    Front Immunol; 2022; 13():1018903. PubMed ID: 36300110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species-powered cancer immunotherapy: Current status and challenges.
    He M; Wang M; Xu T; Zhang M; Dai H; Wang C; Ding D; Zhong Z
    J Control Release; 2023 Apr; 356():623-648. PubMed ID: 36868519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
    Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
    J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformable prodrug nanoplatform
    Yang W; Yi J; Zhu R; Guo Y; Zhang K; Cao Y; Li X; Zhang J; Zhang Z; Li Y; Chen X
    Theranostics; 2023; 13(6):1906-1920. PubMed ID: 37064869
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.
    Jiang T; Chen X; Ren X; Yang JM; Cheng Y
    Drug Resist Updat; 2021 May; 56():100752. PubMed ID: 33765484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy.
    Wu YH; Chen RJ; Chiu HW; Yang LX; Wang YL; Chen YY; Yeh YL; Liao MY; Wang YJ
    Theranostics; 2023; 13(1):40-58. PubMed ID: 36593951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative Stress.
    Lin A; Truong B; Patel S; Kaushik N; Choi EH; Fridman G; Fridman A; Miller V
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1.
    Tan H; Liu J; Huang J; Li Y; Xie Q; Dong Y; Mi Z; Ma X; Rong P
    J Transl Med; 2023 Jul; 21(1):462. PubMed ID: 37438720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications.
    Zhai X; Lin Y; Zhu L; Wang Y; Zhang J; Liu J; Li L; Lu X
    Cytokine Growth Factor Rev; 2024 Feb; 75():101-109. PubMed ID: 37658030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor Effects of a Distinct Sonodynamic Nanosystem through Enhanced Induction of Immunogenic Cell Death and Ferroptosis with Modulation of Tumor Microenvironment.
    Yuan H; Ma J; Huang W; Gong P; Shi F; Xu X; Fu C; Wang X; Wong YK; Long Y; Sun X; Li W; Li Z; Wang J
    JACS Au; 2023 May; 3(5):1507-1520. PubMed ID: 37234112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer.
    Wang X; Zhou L; Wang H; Chen W; Jiang L; Ming G; Wang J
    Cancer Med; 2023 Nov; 12(21):20573-20589. PubMed ID: 37860928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
    Darragh LB; Oweida AJ; Karam SD
    Front Immunol; 2018; 9():3154. PubMed ID: 30766539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.